Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Perspective

ISCT 2018 Commercialization Signature Series

PERSPECTIVE

The second ISCT Commercialization Committee Signature Series was held this past January at the Phacilitate meeting. After a successful inaugural event in 2016 at the ISCT North American Regional Meeting, focused on a broad overview of challenges and roadblocks to commercialization, this event turned it’s focus towards product characterization and comparability, essential topics to adequately harness and control any product development, but of particular complexity in the context of live replicating cell products.

DOI: 10.18609/cgti.2018.047
Citation: Cell Gene Therapy Insights 2018; 4(5), 437-456.
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog